BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma

$327,515P01FY2021CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Damian J. Greencontact

Linked publications & trials

Paper 39763516 Paper 39682018 Paper 39606437 Paper 39374522 Paper 39210036 Paper 39169114 Paper 38914227 Paper 38895348 Paper 38828727 Paper 38746248 Paper 38388647 Paper 38380817 Paper 38354704 Paper 37699001 Paper 37655310 Paper 37477588 Paper 37414012 Paper 37394113 Paper 36577856 Paper 36469024 Paper 36369996 Paper 36179985 Paper 36134457 Paper 36088654 Paper 36064752 Paper 36057421 Paper 36030308 Paper 35924583 Paper 35718343 Paper 35584396 Paper 35447514 Paper 35440690 Paper 35292391 Paper 35288345 Paper 35264436 Paper 35235948 Paper 35210305 Paper 35173288 Paper 35138909 Paper 35106927 Paper 35095100 Paper 35007144 Paper 34996099 Paper 34995355 Paper 34741096 Paper 34702753 Paper 34535014 Paper 34269803 Paper 34086185 Paper 34013294 Paper 33914708 Paper 33792629 Paper 33775588 Paper 33750070 Paper 33121238 Paper 33064008 Paper 33002641 Paper 32988787 Paper 32970635 Paper 32860705 Paper 32825022 Paper 32693210 Paper 32687560 Paper 32603426 Paper 32582592 Paper 32483623 Paper 32479188 Paper 32227211 Paper 31974434 Paper 31958813 Paper 31916007 Paper 31821885 Paper 31796913 Paper 31682980 Paper 31678540 Paper 31669248 Paper 31605822 Paper 31558788 Paper 31558469 Paper 31551243 Paper 31481800 Paper 31337659 Paper 31289199 Paper 31255743 Paper 31248843 Paper 31235963 Paper 31186276 Paper 31028033 Paper 31014151 Paper 30992266 Paper 30940363 Paper 30804488 Paper 30668198 Paper 30539318 Paper 30466757 Paper 30442722 Paper 30429336 Paper 30262560 Paper 30098393 Paper 30042204

View original record on NIH RePORTER →